Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
Volume 0.37M
Average 0.43M
ODTX Operating Cash Flow
Cash generated by the company's core business operations during the period.
Operating Cash Flow history
Currency unavailable · from the cash flow
No Operating Cash Flow data reported for this period type.
Operating Cash Flow vs competitors
How ODTX compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
ALMSAlumis Inc. Common Stock | LTM Jun 2026 | $351.4M USD | +1.8% | +50.8% | 4749.9% |
| LTM Sep 2026 | $249.32M USD | +54.0% | +28.3% | 275.5% | |
| LTM Jun 2026 | $131.2M USD | +231.8% | — | 46.5% | |
ORKAOruka Therapeutics, Inc. | LTM Sep 2026 | $123.64M USD | +46.4% | +100.7% | — |
| LTM Mar 2026 | $81.33M USD | -1.5% | +9.6% | — | |
| LTM Mar 2026 | $52.21M USD | +323.8% | -11.3% | 623.9% | |
| LTM Mar 2026 | $4.48M USD | +104.1% | — | 1.9% | |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | — | — | — | — | — |
| Peer median (excluding ODTX) | — | +54.0% | +28.3% | 275.5% | |
Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Odyssey Therapeutics, Inc.
NASDAQ:ODTX
Intrinsic Alpha fair value
Locked
Current Price
$18.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.